Does TREPROSTINIL Cause Therapy non-responder? 2,289 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 2,289 reports of Therapy non-responder have been filed in association with TREPROSTINIL (TYVASO). This represents 2.5% of all adverse event reports for TREPROSTINIL.
2,289
Reports of Therapy non-responder with TREPROSTINIL
2.5%
of all TREPROSTINIL reports
125
Deaths
620
Hospitalizations
How Dangerous Is Therapy non-responder From TREPROSTINIL?
Of the 2,289 reports, 125 (5.5%) resulted in death, 620 (27.1%) required hospitalization, and 44 (1.9%) were considered life-threatening.
Is Therapy non-responder Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TREPROSTINIL. However, 2,289 reports have been filed with the FAERS database.
What Other Side Effects Does TREPROSTINIL Cause?
Dyspnoea (16,348)
Headache (14,051)
Diarrhoea (11,335)
Nausea (10,320)
Cough (8,945)
Fatigue (7,440)
Dizziness (7,405)
Infusion site pain (5,169)
Vomiting (5,097)
Death (4,764)
What Other Drugs Cause Therapy non-responder?
ETANERCEPT (3,472)
APREMILAST (3,360)
METHOTREXATE (2,965)
RITUXIMAB (2,731)
ADALIMUMAB (2,595)
PREDNISONE (2,563)
INFLIXIMAB (2,122)
TOCILIZUMAB (1,775)
HYDROXYCHLOROQUINE (1,699)
ABATACEPT (1,615)
Which TREPROSTINIL Alternatives Have Lower Therapy non-responder Risk?
TREPROSTINIL vs TREPROSTINIL DIOLAMINE
TREPROSTINIL vs TRETINOIN
TREPROSTINIL vs TRIAMCINOLONE
TREPROSTINIL vs TRIAMCINOLONE ACETONIDE
TREPROSTINIL vs TRIAMCINOLONE HEXACETONIDE